Scleroderma Therapeutics Market 2024-2028- Product Image

New

Scleroderma Therapeutics Market 2024-2028

Report
130 Pages
July 2024
Region: Global
TechNavio
ID: 5558026

The scleroderma therapeutics market is forecasted to grow by USD 467 million during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the scleroderma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high unmet medical needs, rising focus on awareness-raising initiatives, and increased funding for R&D activities.

The scleroderma therapeutics market is segmented as below:

By Disease Type

Localized scleroderma
Systemic scleroderma

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the introduction of stem cell therapy in scleroderma treatment as one of the prime reasons driving the scleroderma therapeutics market growth during the next few years. Also, advent of novel therapies and partnerships and strategic alliances will lead to sizable demand in the market.

The report on the scleroderma therapeutics market covers the following areas:

Scleroderma therapeutics market sizing
Scleroderma therapeutics market forecast
Scleroderma therapeutics market industry analysis

A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading scleroderma therapeutics market vendors that include AbbVie Inc., Akashi Therapeutics, Amneal Pharmaceuticals Inc., ANTARES PHARMA INC., Argentis Pharmaceuticals LLC, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Castle Creek Biosciences Inc., Chemomab Therapeutics Ltd., Corbus Pharmaceuticals Holdings Inc, Cumberland Pharmaceuticals Inc., Emerald Health Pharmaceuticals, F. Hoffmann La Roche Ltd., Medexus Pharmaceuticals Inc., Novartis AG, Pfizer Inc., Sanofi SA, and The Procter and Gamble Co. Also, the scleroderma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Disease Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing

3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Scleroderma Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Scleroderma Therapeutics Market 2018 - 2022 ($ million)
4.2 Disease Type segment analysis 2018 - 2022
Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Disease Type

6.1 Market segments
Chart on Disease Type - Market share 2023-2028 (%)
Data Table on Disease Type - Market share 2023-2028 (%)
6.2 Comparison by Disease Type
Chart on Comparison by Disease Type
Data Table on Comparison by Disease Type
6.3 Localized scleroderma - Market size and forecast 2023-2028
Chart on Localized scleroderma - Market size and forecast 2023-2028 ($ million)
Data Table on Localized scleroderma - Market size and forecast 2023-2028 ($ million)
Chart on Localized scleroderma - Year-over-year growth 2023-2028 (%)
Data Table on Localized scleroderma - Year-over-year growth 2023-2028 (%)
6.4 Systemic scleroderma - Market size and forecast 2023-2028
Chart on Systemic scleroderma - Market size and forecast 2023-2028 ($ million)
Data Table on Systemic scleroderma - Market size and forecast 2023-2028 ($ million)
Chart on Systemic scleroderma - Year-over-year growth 2023-2028 (%)
Data Table on Systemic scleroderma - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Disease Type
Market opportunity by Disease Type ($ million)
Data Table on Market opportunity by Disease Type ($ million)

7 Customer Landscape

7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.8 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.9 Denmark - Market size and forecast 2023-2028
Chart on Denmark - Market size and forecast 2023-2028 ($ million)
Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
Chart on Denmark - Year-over-year growth 2023-2028 (%)
Data Table on Denmark - Year-over-year growth 2023-2028 (%)
8.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.11 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Akashi Therapeutics
Akashi Therapeutics - Overview
Akashi Therapeutics - Product / Service
Akashi Therapeutics - Key offerings
11.4 Argentis Pharmaceuticals LLC
Argentis Pharmaceuticals LLC - Overview
Argentis Pharmaceuticals LLC - Product / Service
Argentis Pharmaceuticals LLC - Key offerings
11.5 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
11.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
11.7 Castle Creek Biosciences Inc.
Castle Creek Biosciences Inc. - Overview
Castle Creek Biosciences Inc. - Product / Service
Castle Creek Biosciences Inc. - Key offerings
11.8 Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. - Overview
Chemomab Therapeutics Ltd. - Product / Service
Chemomab Therapeutics Ltd. - Key offerings
11.9 Corbus Pharmaceuticals Holdings Inc
Corbus Pharmaceuticals Holdings Inc - Overview
Corbus Pharmaceuticals Holdings Inc - Product / Service
Corbus Pharmaceuticals Holdings Inc - Key offerings
11.10 Emerald Health Pharmaceuticals
Emerald Health Pharmaceuticals - Overview
Emerald Health Pharmaceuticals - Product / Service
Emerald Health Pharmaceuticals - Key offerings
11.11 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.12 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Scleroderma Therapeutics Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Disease Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Disease Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Disease Type
Exhibits 33: Data Table on Comparison by Disease Type
Exhibits 34: Chart on Localized scleroderma - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Localized scleroderma - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Localized scleroderma - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Localized scleroderma - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Systemic scleroderma - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Systemic scleroderma - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Systemic scleroderma - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Systemic scleroderma - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Disease Type ($ million)
Exhibits 43: Data Table on Market opportunity by Disease Type ($ million)
Exhibits 44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 47: Chart on Geographic comparison
Exhibits 48: Data Table on Geographic comparison
Exhibits 49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Denmark - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Denmark - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 85: Market opportunity By Geographical Landscape ($ million)
Exhibits 86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2023 and 2028
Exhibits 88: Overview on criticality of inputs and factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Companies covered
Exhibits 92: Matrix on companies position and classification
Exhibits 93: Akashi Therapeutics - Overview
Exhibits 94: Akashi Therapeutics - Product / Service
Exhibits 95: Akashi Therapeutics - Key offerings
Exhibits 96: Argentis Pharmaceuticals LLC - Overview
Exhibits 97: Argentis Pharmaceuticals LLC - Product / Service
Exhibits 98: Argentis Pharmaceuticals LLC - Key offerings
Exhibits 99: Boehringer Ingelheim International GmbH - Overview
Exhibits 100: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 101: Boehringer Ingelheim International GmbH - Key news
Exhibits 102: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 103: Bristol Myers Squibb Co. - Overview
Exhibits 104: Bristol Myers Squibb Co. - Product / Service
Exhibits 105: Bristol Myers Squibb Co. - Key news
Exhibits 106: Bristol Myers Squibb Co. - Key offerings
Exhibits 107: Castle Creek Biosciences Inc. - Overview
Exhibits 108: Castle Creek Biosciences Inc. - Product / Service
Exhibits 109: Castle Creek Biosciences Inc. - Key offerings
Exhibits 110: Chemomab Therapeutics Ltd. - Overview
Exhibits 111: Chemomab Therapeutics Ltd. - Product / Service
Exhibits 112: Chemomab Therapeutics Ltd. - Key offerings
Exhibits 113: Corbus Pharmaceuticals Holdings Inc - Overview
Exhibits 114: Corbus Pharmaceuticals Holdings Inc - Product / Service
Exhibits 115: Corbus Pharmaceuticals Holdings Inc - Key offerings
Exhibits 116: Emerald Health Pharmaceuticals - Overview
Exhibits 117: Emerald Health Pharmaceuticals - Product / Service
Exhibits 118: Emerald Health Pharmaceuticals - Key offerings
Exhibits 119: F. Hoffmann La Roche Ltd. - Overview
Exhibits 120: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 121: F. Hoffmann La Roche Ltd. - Key news
Exhibits 122: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 123: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 124: Sanofi SA - Overview
Exhibits 125: Sanofi SA - Business segments
Exhibits 126: Sanofi SA - Key news
Exhibits 127: Sanofi SA - Key offerings
Exhibits 128: Sanofi SA - Segment focus
Exhibits 129: Inclusions checklist
Exhibits 130: Exclusions checklist
Exhibits 131: Currency conversion rates for US$
Exhibits 132: Research methodology
Exhibits 133: Information sources
Exhibits 134: Data validation
Exhibits 135: Validation techniques employed for market sizing
Exhibits 136: Data synthesis
Exhibits 137: 360 degree market analysis
Exhibits 138: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global scleroderma therapeutics market: AbbVie Inc., Akashi Therapeutics, Amneal Pharmaceuticals Inc., ANTARES PHARMA INC., Argentis Pharmaceuticals LLC, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Castle Creek Biosciences Inc., Chemomab Therapeutics Ltd., Corbus Pharmaceuticals Holdings Inc, Cumberland Pharmaceuticals Inc., Emerald Health Pharmaceuticals, F. Hoffmann La Roche Ltd., Medexus Pharmaceuticals Inc., Novartis AG, Pfizer Inc., Sanofi SA, and The Procter and Gamble Co..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is introduction of STEM cell therapy in scleroderma treatment."

According to the report, one of the major drivers for this market is the high unmet medical needs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AbbVie Inc.
Akashi Therapeutics
Amneal Pharmaceuticals Inc.
ANTARES PHARMA INC.
Argentis Pharmaceuticals LLC
AstraZeneca Plc
Bayer AG
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Co.
Castle Creek Biosciences Inc.
Chemomab Therapeutics Ltd.
Corbus Pharmaceuticals Holdings Inc
Cumberland Pharmaceuticals Inc.
Emerald Health Pharmaceuticals
F. Hoffmann La Roche Ltd.
Medexus Pharmaceuticals Inc.
Novartis AG
Pfizer Inc.
Sanofi SA
The Procter and Gamble Co.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2464EUR$2,500USD£2,038GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3943EUR$4,000USD£3,260GBP

The scleroderma therapeutics market is segmented as below:

By Disease Type

By Geographical Landscape

The report on the scleroderma therapeutics market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Scleroderma Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Immunosuppressors, ERA, CCBs, PA), By Indication (Systemic, Localized), By Region, And Segment Forecasts, 2025 - 2030

Scleroderma Diagnostics and Therapeutics - Global Strategic Business Report

Scleroderma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

Scleroderma Diagnostics & Therapeutics Market by Diagnostic Tests, Drug Type, Therapeutics, Indication - Global Forecast 2025-2030

Scleroderma Diagnostics and Therapeutics Market by Disease Type, by Drugs, by Diagnosis, by End-User, and By Region